Global Nanopharmaceuticals Market Growth 2020-2025

Publisher Name :
Date: 28-Sep-2020
No. of pages: 179

According to this study, over the next five years the Nanopharmaceuticals market will register a 13.5%% CAGR in terms of revenue, the global market size will reach $ 38980 million by 2025, from $ 23500 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Nanopharmaceuticals business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Nanopharmaceuticals market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Nanopharmaceuticals, covering the supply chain analysis, impact assessment to the Nanopharmaceuticals market size growth rate in several scenarios, and the measures to be undertaken by Nanopharmaceuticals companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

- Liposomes

- Polymeric Micelles

- Solid Lipid Nanoparticles

- Microemulsion and Nnanoemulsion

- Nanosuspension

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

- Cancer and Tumor

- Autoimmune Disorders

- Inflammation

- Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- United States

- Canada

- Mexico

- Brazil

- APAC

- China

- Japan

- Korea

- Southeast Asia

- India

- Australia

- Europe

- Germany

- France

- UK

- Italy

- Russia

- Middle East & Africa

- Egypt

- South Africa

- Israel

- Turkey

- GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- Merck

- Johnson & Johnson

- Pfizer

- Abbott

- GlaxoSmithKline

- Novartis

- Eli Lilly

- Roche

- Astrazeneca

- Sanofi

- Kadmon Pharmaceuticals

- Mitsubishi Pharma

- Samyang Biopharm

- Celgene

- Gilead Sciences

- Stryker

- Selecta Biosciences

- OSI Pharmaceuticals

- Novavax

- Kaken Pharmaceutical

- Cerulean Pharma

- Navidea Biopharmaceuticals

- Par Pharmaceutical

- Lummy

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Nanopharmaceuticals consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

- To understand the structure of Nanopharmaceuticals market by identifying its various subsegments.

- Focuses on the key global Nanopharmaceuticals manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Nanopharmaceuticals with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Nanopharmaceuticals submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Nanopharmaceuticals Market Growth 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nanopharmaceuticals Consumption 2015-2025
2.1.2 Nanopharmaceuticals Consumption CAGR by Region
2.2 Nanopharmaceuticals Segment by Type
2.2.1 Liposomes
2.2.2 Polymeric Micelles
2.2.3 Solid Lipid Nanoparticles
2.2.4 Microemulsion and Nnanoemulsion
2.2.5 Nanosuspension
2.3 Nanopharmaceuticals Consumption by Type
2.3.1 Global Nanopharmaceuticals Consumption Market Share by Type (2015-2020)
2.3.2 Global Nanopharmaceuticals Revenue and Market Share by Type (2015-2020)
2.3.3 Global Nanopharmaceuticals Sale Price by Type (2015-2020)
2.4 Nanopharmaceuticals Segment by Application
2.4.1 Cancer and Tumor
2.4.2 Autoimmune Disorders
2.4.3 Inflammation
2.4.4 Others
2.5 Nanopharmaceuticals Consumption by Application
2.5.1 Global Nanopharmaceuticals Consumption Market Share by Type (2015-2020)
2.5.2 Global Nanopharmaceuticals Value and Market Share by Type (2015-2020)
2.5.3 Global Nanopharmaceuticals Sale Price by Type (2015-2020)

3 Global Nanopharmaceuticals by Company
3.1 Global Nanopharmaceuticals Sales Market Share by Company
3.1.1 Global Nanopharmaceuticals Sales by Company (2018-2020)
3.1.2 Global Nanopharmaceuticals Sales Market Share by Company (2018-2020)
3.2 Global Nanopharmaceuticals Revenue Market Share by Company
3.2.1 Global Nanopharmaceuticals Revenue by Company (2018-2020)
3.2.2 Global Nanopharmaceuticals Revenue Market Share by Company (2018-2020)
3.3 Global Nanopharmaceuticals Sale Price by Company
3.4 Global Nanopharmaceuticals Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Nanopharmaceuticals Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Nanopharmaceuticals Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Nanopharmaceuticals by Regions
4.1 Nanopharmaceuticals by Regions
4.2 Americas Nanopharmaceuticals Consumption Growth
4.3 APAC Nanopharmaceuticals Consumption Growth
4.4 Europe Nanopharmaceuticals Consumption Growth
4.5 Middle East & Africa Nanopharmaceuticals Consumption Growth

5 Americas
5.1 Americas Nanopharmaceuticals Consumption by Countries
5.1.1 Americas Nanopharmaceuticals Consumption by Countries (2015-2020)
5.1.2 Americas Nanopharmaceuticals Value by Countries (2015-2020)
5.2 Americas Nanopharmaceuticals Consumption by Type
5.3 Americas Nanopharmaceuticals Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Nanopharmaceuticals Consumption by Regions
6.1.1 APAC Nanopharmaceuticals Consumption by Regions (2015-2020)
6.1.2 APAC Nanopharmaceuticals Value by Regions (2015-2020)
6.2 APAC Nanopharmaceuticals Consumption by Type
6.3 APAC Nanopharmaceuticals Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Nanopharmaceuticals by Countries
7.1.1 Europe Nanopharmaceuticals Consumption by Countries (2015-2020)
7.1.2 Europe Nanopharmaceuticals Value by Countries (2015-2020)
7.2 Europe Nanopharmaceuticals Consumption by Type
7.3 Europe Nanopharmaceuticals Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Nanopharmaceuticals by Countries
8.1.1 Middle East & Africa Nanopharmaceuticals Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Nanopharmaceuticals Value by Countries (2015-2020)
8.2 Middle East & Africa Nanopharmaceuticals Consumption by Type
8.3 Middle East & Africa Nanopharmaceuticals Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Nanopharmaceuticals Distributors
10.3 Nanopharmaceuticals Customer

11 Global Nanopharmaceuticals Market Forecast
11.1 Global Nanopharmaceuticals Consumption Forecast (2021-2025)
11.2 Global Nanopharmaceuticals Forecast by Regions
11.2.1 Global Nanopharmaceuticals Forecast by Regions (2021-2025)
11.2.2 Global Nanopharmaceuticals Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Nanopharmaceuticals Forecast by Type
11.8 Global Nanopharmaceuticals Forecast by Application

12 Key Players Analysis
12.1 Merck
12.1.1 Company Information
12.1.2 Nanopharmaceuticals Product Offered
12.1.3 Merck Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Merck Latest Developments
12.2 Johnson & Johnson
12.2.1 Company Information
12.2.2 Nanopharmaceuticals Product Offered
12.2.3 Johnson & Johnson Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Johnson & Johnson Latest Developments
12.3 Pfizer
12.3.1 Company Information
12.3.2 Nanopharmaceuticals Product Offered
12.3.3 Pfizer Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Pfizer Latest Developments
12.4 Abbott
12.4.1 Company Information
12.4.2 Nanopharmaceuticals Product Offered
12.4.3 Abbott Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Abbott Latest Developments
12.5 GlaxoSmithKline
12.5.1 Company Information
12.5.2 Nanopharmaceuticals Product Offered
12.5.3 GlaxoSmithKline Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 GlaxoSmithKline Latest Developments
12.6 Novartis
12.6.1 Company Information
12.6.2 Nanopharmaceuticals Product Offered
12.6.3 Novartis Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Novartis Latest Developments
12.7 Eli Lilly
12.7.1 Company Information
12.7.2 Nanopharmaceuticals Product Offered
12.7.3 Eli Lilly Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Eli Lilly Latest Developments
12.8 Roche
12.8.1 Company Information
12.8.2 Nanopharmaceuticals Product Offered
12.8.3 Roche Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Roche Latest Developments
12.9 Astrazeneca
12.9.1 Company Information
12.9.2 Nanopharmaceuticals Product Offered
12.9.3 Astrazeneca Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Astrazeneca Latest Developments
12.10 Sanofi
12.10.1 Company Information
12.10.2 Nanopharmaceuticals Product Offered
12.10.3 Sanofi Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Sanofi Latest Developments
12.11 Kadmon Pharmaceuticals
12.11.1 Company Information
12.11.2 Nanopharmaceuticals Product Offered
12.11.3 Kadmon Pharmaceuticals Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Kadmon Pharmaceuticals Latest Developments
12.12 Mitsubishi Pharma
12.12.1 Company Information
12.12.2 Nanopharmaceuticals Product Offered
12.12.3 Mitsubishi Pharma Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Mitsubishi Pharma Latest Developments
12.13 Samyang Biopharm
12.13.1 Company Information
12.13.2 Nanopharmaceuticals Product Offered
12.13.3 Samyang Biopharm Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Samyang Biopharm Latest Developments
12.14 Celgene
12.14.1 Company Information
12.14.2 Nanopharmaceuticals Product Offered
12.14.3 Celgene Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Celgene Latest Developments
12.15 Gilead Sciences
12.15.1 Company Information
12.15.2 Nanopharmaceuticals Product Offered
12.15.3 Gilead Sciences Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Gilead Sciences Latest Developments
12.16 Stryker
12.16.1 Company Information
12.16.2 Nanopharmaceuticals Product Offered
12.16.3 Stryker Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Stryker Latest Developments
12.17 Selecta Biosciences
12.17.1 Company Information
12.17.2 Nanopharmaceuticals Product Offered
12.17.3 Selecta Biosciences Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Selecta Biosciences Latest Developments
12.18 OSI Pharmaceuticals
12.18.1 Company Information
12.18.2 Nanopharmaceuticals Product Offered
12.18.3 OSI Pharmaceuticals Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.18.4 Main Business Overview
12.18.5 OSI Pharmaceuticals Latest Developments
12.19 Novavax
12.19.1 Company Information
12.19.2 Nanopharmaceuticals Product Offered
12.19.3 Novavax Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.19.4 Main Business Overview
12.19.5 Novavax Latest Developments
12.20 Kaken Pharmaceutical
12.20.1 Company Information
12.20.2 Nanopharmaceuticals Product Offered
12.20.3 Kaken Pharmaceutical Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.20.4 Main Business Overview
12.20.5 Kaken Pharmaceutical Latest Developments
12.21 Cerulean Pharma
12.21.1 Company Information
12.21.2 Nanopharmaceuticals Product Offered
12.21.3 Cerulean Pharma Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.21.4 Main Business Overview
12.21.5 Cerulean Pharma Latest Developments
12.22 Navidea Biopharmaceuticals
12.22.1 Company Information
12.22.2 Nanopharmaceuticals Product Offered
12.22.3 Navidea Biopharmaceuticals Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.22.4 Main Business Overview
12.22.5 Navidea Biopharmaceuticals Latest Developments
12.23 Par Pharmaceutical
12.23.1 Company Information
12.23.2 Nanopharmaceuticals Product Offered
12.23.3 Par Pharmaceutical Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.23.4 Main Business Overview
12.23.5 Par Pharmaceutical Latest Developments
12.24 Lummy
12.24.1 Company Information
12.24.2 Nanopharmaceuticals Product Offered
12.24.3 Lummy Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.24.4 Main Business Overview
12.24.5 Lummy Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Nanopharmaceuticals Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Liposomes
Table 5. Major Players of Polymeric Micelles
Table 6. Major Players of Solid Lipid Nanoparticles
Table 7. Major Players of Microemulsion and Nnanoemulsion
Table 8. Major Players of Nanosuspension
Table 9. Global Consumption Sales by Type (2015-2020)
Table 10. Global Nanopharmaceuticals Consumption Market Share by Type (2015-2020)
Table 11. Global Nanopharmaceuticals Revenue by Type (2015-2020) ($ million)
Table 12. Global Nanopharmaceuticals Value Market Share by Type (2015-2020) ($ Millions)
Table 13. Global Nanopharmaceuticals Sale Price by Type (2015-2020)
Table 14. Global Consumption Sales by Application (2015-2020)
Table 15. Global Nanopharmaceuticals Consumption Market Share by Application (2015-2020)
Table 16. Global Nanopharmaceuticals Value by Application (2015-2020)
Table 17. Global Nanopharmaceuticals Value Market Share by Application (2015-2020)
Table 18. Global Nanopharmaceuticals Sale Price by Application (2015-2020)
Table 19. Global Nanopharmaceuticals Sales by Company (2017-2019) (K MT)
Table 20. Global Nanopharmaceuticals Sales Market Share by Company (2017-2019)
Table 21. Global Nanopharmaceuticals Revenue by Company (2017-2019) ($ Millions)
Table 22. Global Nanopharmaceuticals Revenue Market Share by Company (2017-2019)
Table 23. Global Nanopharmaceuticals Sale Price by Company (2017-2019)
Table 24. Global Nanopharmaceuticals Manufacturing Base Distribution and Sales Area by Manufacturers
Table 25. Players Nanopharmaceuticals Products Offered
Table 26. Nanopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 27. Global Nanopharmaceuticals Consumption by Regions 2015-2020 (K MT)
Table 28. Global Nanopharmaceuticals Consumption Market Share by Regions 2015-2020
Table 29. Global Nanopharmaceuticals Value by Regions 2015-2020 ($ Millions)
Table 30. Global Nanopharmaceuticals Value Market Share by Regions 2015-2020
Table 31. Americas Nanopharmaceuticals Consumption by Countries (2015-2020) (K MT)
Table 32. Americas Nanopharmaceuticals Consumption Market Share by Countries (2015-2020)
Table 33. Americas Nanopharmaceuticals Value by Countries (2015-2020) ($ Millions)
Table 34. Americas Nanopharmaceuticals Value Market Share by Countries (2015-2020)
Table 35. Americas Nanopharmaceuticals Consumption by Type (2015-2020) (K MT)
Table 36. Americas Nanopharmaceuticals Consumption Market Share by Type (2015-2020)
Table 37. Americas Nanopharmaceuticals Consumption by Application (2015-2020) (K MT)
Table 38. Americas Nanopharmaceuticals Consumption Market Share by Application (2015-2020)
Table 39. APAC Nanopharmaceuticals Consumption by Countries (2015-2020) (K MT)
Table 40. APAC Nanopharmaceuticals Consumption Market Share by Countries (2015-2020)
Table 41. APAC Nanopharmaceuticals Value by Regions (2015-2020) ($ Millions)
Table 42. APAC Nanopharmaceuticals Value Market Share by Regions (2015-2020)
Table 43. APAC Nanopharmaceuticals Consumption by Type (2015-2020) (K MT)
Table 44. APAC Nanopharmaceuticals Consumption Market Share by Type (2015-2020)
Table 45. APAC Nanopharmaceuticals Consumption by Application (2015-2020) (K MT)
Table 46. APAC Nanopharmaceuticals Consumption Market Share by Application (2015-2020)
Table 47. Europe Nanopharmaceuticals Consumption by Countries (2015-2020) (K MT)
Table 48. Europe Nanopharmaceuticals Consumption Market Share by Countries (2015-2020)
Table 49. Europe Nanopharmaceuticals Value by Countries (2015-2020) ($ Millions)
Table 50. Europe Nanopharmaceuticals Value Market Share by Countries (2015-2020)
Table 51. Europe Nanopharmaceuticals Consumption by Type (2015-2020) (K MT)
Table 52. Europe Nanopharmaceuticals Consumption Market Share by Type (2015-2020)
Table 53. Europe Nanopharmaceuticals Consumption by Application (2015-2020) (K MT)
Table 54. Europe Nanopharmaceuticals Consumption Market Share by Application (2015-2020)
Table 55. Middle East & Africa Nanopharmaceuticals Consumption by Countries (2015-2020) (K MT)
Table 56. Middle East & Africa Nanopharmaceuticals Consumption Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Nanopharmaceuticals Value by Countries (2015-2020) ($ Millions)
Table 58. Middle East & Africa Nanopharmaceuticals Value Market Share by Countries (2015-2020)
Table 59. Middle East & Africa Nanopharmaceuticals Consumption by Type (2015-2020) (K MT)
Table 60. Middle East & Africa Nanopharmaceuticals Consumption Market Share by Type (2015-2020)
Table 61. Middle East & Africa Nanopharmaceuticals Consumption by Application (2015-2020) (K MT)
Table 62. Middle East & Africa Nanopharmaceuticals Consumption Market Share by Application (2015-2020)
Table 63. Nanopharmaceuticals Distributors List
Table 64. Nanopharmaceuticals Customer List
Table 65. Global Nanopharmaceuticals Consumption Forecast by Countries (2021-2025) (K MT)
Table 66. Global Nanopharmaceuticals Consumption Market Forecast by Regions
Table 67. Global Nanopharmaceuticals Value Forecast by Countries (2021-2025) ($ Millions)
Table 68. Global Nanopharmaceuticals Value Market Share Forecast by Regions
Table 69. Global Nanopharmaceuticals Consumption Forecast by Type (2021-2025) (K MT)
Table 70. Global Nanopharmaceuticals Consumption Market Share Forecast by Type (2021-2025)
Table 71. Global Nanopharmaceuticals Value Forecast by Type (2021-2025) ($ Millions)
Table 72. Global Nanopharmaceuticals Value Market Share Forecast by Type (2021-2025)
Table 73. Global Nanopharmaceuticals Consumption Forecast by Application (2021-2025) (K MT)
Table 74. Global Nanopharmaceuticals Consumption Market Share Forecast by Application (2021-2025)
Table 75. Global Nanopharmaceuticals Value Forecast by Application (2021-2025) ($ Millions)
Table 76. Global Nanopharmaceuticals Value Market Share Forecast by Application (2021-2025)
Table 77. Merck Product Offered
Table 78. Merck Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 79. Merck Main Business
Table 80. Merck Latest Developments
Table 81. Merck Basic Information, Company Total Revenue (in $ million), Nanopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 82. Johnson & Johnson Product Offered
Table 83. Johnson & Johnson Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 84. Johnson & Johnson Main Business
Table 85. Johnson & Johnson Latest Developments
Table 86. Johnson & Johnson Basic Information, Company Total Revenue (in $ million), Nanopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 87. Pfizer Product Offered
Table 88. Pfizer Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 89. Pfizer Main Business
Table 90. Pfizer Latest Developments
Table 91. Pfizer Basic Information, Company Total Revenue (in $ million), Nanopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 92. Abbott Product Offered
Table 93. Abbott Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 94. Abbott Main Business
Table 95. Abbott Latest Developments
Table 96. Abbott Basic Information, Company Total Revenue (in $ million), Nanopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 97. GlaxoSmithKline Product Offered
Table 98. GlaxoSmithKline Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 99. GlaxoSmithKline Main Business
Table 100. GlaxoSmithKline Latest Developments
Table 101. GlaxoSmithKline Basic Information, Company Total Revenue (in $ million), Nanopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 102. Novartis Product Offered
Table 103. Novartis Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 104. Novartis Main Business
Table 105. Novartis Latest Developments
Table 106. Novartis Basic Information, Company Total Revenue (in $ million), Nanopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 107. Eli Lilly Product Offered
Table 108. Eli Lilly Basic Information, Company Total Revenue (in $ million), Nanopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 109. Eli Lilly Main Business
Table 110. Eli Lilly Latest Developments
Table 111. Eli Lilly Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 112. Roche Product Offered
Table 113. Roche Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 114. Roche Main Business
Table 115. Roche Latest Developments
Table 116. Roche Basic Information, Company Total Revenue (in $ million), Nanopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 117. Astrazeneca Product Offered
Table 118. Astrazeneca Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 119. Astrazeneca Main Business
Table 120. Astrazeneca Latest Developments
Table 121. Astrazeneca Basic Information, Company Total Revenue (in $ million), Nanopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 122. Sanofi Product Offered
Table 123. Sanofi Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 124. Sanofi Main Business
Table 125. Sanofi Latest Developments
Table 126. Sanofi Basic Information, Company Total Revenue (in $ million), Nanopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 127. Kadmon Pharmaceuticals Product Offered
Table 128. Kadmon Pharmaceuticals Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 129. Kadmon Pharmaceuticals Main Business
Table 130. Kadmon Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 131. Kadmon Pharmaceuticals Latest Developments
Table 132. Mitsubishi Pharma Product Offered
Table 133. Mitsubishi Pharma Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 134. Mitsubishi Pharma Main Business
Table 135. Mitsubishi Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 136. Mitsubishi Pharma Latest Developments
Table 137. Samyang Biopharm Product Offered
Table 138. Samyang Biopharm Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 139. Samyang Biopharm Main Business
Table 140. Samyang Biopharm Latest Developments
Table 141. Samyang Biopharm Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 142. Celgene Product Offered
Table 143. Celgene Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 144. Celgene Main Business
Table 145. Celgene Latest Developments
Table 146. Celgene Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 147. Gilead Sciences Product Offered
Table 148. Gilead Sciences Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 149. Gilead Sciences Main Business
Table 150. Gilead Sciences Latest Developments
Table 151. Gilead Sciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 152. Stryker Product Offered
Table 153. Stryker Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 154. Stryker Main Business
Table 155. Stryker Latest Developments
Table 156. Stryker Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 157. Selecta Biosciences Product Offered
Table 158. Selecta Biosciences Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 159. Selecta Biosciences Main Business
Table 160. Selecta Biosciences Latest Developments
Table 161. Selecta Biosciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 162. OSI Pharmaceuticals Product Offered
Table 163. OSI Pharmaceuticals Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 164. OSI Pharmaceuticals Main Business
Table 165. OSI Pharmaceuticals Latest Developments
Table 166. OSI Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 167. Novavax Product Offered
Table 168. Novavax Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 169. Novavax Main Business
Table 170. Novavax Latest Developments
Table 171. Novavax Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 172. Kaken Pharmaceutical Product Offered
Table 173. Kaken Pharmaceutical Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 174. Kaken Pharmaceutical Main Business
Table 175. Kaken Pharmaceutical Latest Developments
Table 176. Kaken Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 177. Cerulean Pharma Product Offered
Table 178. Cerulean Pharma Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 179. Cerulean Pharma Main Business
Table 180. Cerulean Pharma Latest Developments
Table 181. Cerulean Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 182. Navidea Biopharmaceuticals Product Offered
Table 183. Navidea Biopharmaceuticals Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 184. Navidea Biopharmaceuticals Main Business
Table 185. Navidea Biopharmaceuticals Latest Developments
Table 186. Navidea Biopharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 187. Par Pharmaceutical Product Offered
Table 188. Par Pharmaceutical Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 189. Par Pharmaceutical Main Business
Table 190. Par Pharmaceutical Latest Developments
Table 191. Par Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 192. Lummy Product Offered
Table 193. Lummy Nanopharmaceuticals Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 194. Lummy Main Business
Table 195. Lummy Latest Developments
Table 196. Lummy Basic Information, Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Nanopharmaceuticals
Figure 2. Nanopharmaceuticals Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Nanopharmaceuticals Consumption Growth Rate 2015-2025 (K MT)
Figure 5. Global Nanopharmaceuticals Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Liposomes
Figure 7. Product Picture of Polymeric Micelles
Figure 8. Product Picture of Solid Lipid Nanoparticles
Figure 9. Product Picture of Microemulsion and Nnanoemulsion
Figure 10. Product Picture of Nanosuspension
Figure 11. Global Nanopharmaceuticals Consumption Market Share by Type (2015-2020)
Figure 12. Global Nanopharmaceuticals Value Market Share by Type (2015-2020)
Figure 13. Nanopharmaceuticals Consumed in Cancer and Tumor
Figure 14. Global Nanopharmaceuticals Market: Cancer and Tumor (2015-2020) (K MT)
Figure 15. Global Nanopharmaceuticals Market: Cancer and Tumor (2015-2020) ($ Millions)
Figure 16. Nanopharmaceuticals Consumed in Autoimmune Disorders
Figure 17. Global Nanopharmaceuticals Market: Autoimmune Disorders (2015-2020) (K MT)
Figure 18. Global Nanopharmaceuticals Market: Autoimmune Disorders (2015-2020) ($ Millions)
Figure 19. Nanopharmaceuticals Consumed in Inflammation
Figure 20. Global Nanopharmaceuticals Market: Inflammation (2015-2020) (K MT)
Figure 21. Global Nanopharmaceuticals Market: Inflammation (2015-2020) ($ Millions)
Figure 22. Nanopharmaceuticals Consumed in Others
Figure 23. Global Nanopharmaceuticals Market: Others (2015-2020) (K MT)
Figure 24. Global Nanopharmaceuticals Market: Others (2015-2020) ($ Millions)
Figure 25. Global Nanopharmaceuticals Consumption Market Share by Application (2015-2020)
Figure 26. Global Nanopharmaceuticals Value Market Share by Application (2015-2020)
Figure 27. Global Nanopharmaceuticals Sales Market Share by Company in 2017
Figure 28. Global Nanopharmaceuticals Sales Market Share by Company in 2019
Figure 29. Global Nanopharmaceuticals Revenue Market Share by Company in 2017
Figure 30. Global Nanopharmaceuticals Revenue Market Share by Company in 2019
Figure 31. Global Nanopharmaceuticals Sale Price by Company in 2019
Figure 32. Global Nanopharmaceuticals Consumption Market Share by Regions 2015-2020
Figure 33. Global Nanopharmaceuticals Value Market Share by Regions 2015-2020
Figure 34. Americas Nanopharmaceuticals Consumption 2015-2020 (K MT)
Figure 35. Americas Nanopharmaceuticals Value 2015-2020 ($ Millions)
Figure 36. APAC Nanopharmaceuticals Consumption 2015-2020 (K MT)
Figure 37. APAC Nanopharmaceuticals Value 2015-2020 ($ Millions)
Figure 38. Europe Nanopharmaceuticals Consumption 2015-2020 (K MT)
Figure 39. Europe Nanopharmaceuticals Value 2015-2020 ($ Millions)
Figure
  • (COVID-19 Version) Global Nanopharmaceuticals Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 24-Oct-2020        Price: US 3000 Onwards        Pages: 149
    Summary The report forecast global Nanopharmaceuticals market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Nanopharmaceuticals industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Nanopharmaceuticals by geogr......
  • COVID-19 World Nanopharmaceuticals Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 16-Oct-2020        Price: US 2800 Onwards        Pages: 149
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. The report includes as follows: The report provides current data, historical overview and future forecast. The report includes an in-depth analysis of the Global market for Nanopharmaceuticals , covering Global to......
  • Global Nanopharmaceuticals Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 06-Oct-2020        Price: US 3400 Onwards        Pages: 122
    The Nanopharmaceuticals market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Nanopharmaceuticals market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Nanopharmaceuticals market. The report focuses on well-known providers in the global Nanopharmaceuticals industry, market segments, competition, and......
  • Global Nanopharmaceuticals Market Growth 2020-2025
    Published: 28-Sep-2020        Price: US 3660 Onwards        Pages: 179
    According to this study, over the next five years the Nanopharmaceuticals market will register a 13.5%% CAGR in terms of revenue, the global market size will reach $ 38980 million by 2025, from $ 23500 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Nanopharmaceuticals business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Nanopharmaceuticals marke......
  • (COVID-19 Version) Global Nanomedicine Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 19-Sep-2020        Price: US 3000 Onwards        Pages: 95
    Summary The report forecast global Nanomedicine market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Nanomedicine industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Nanomedicine By geography. The repo......
  • COVID-19 World Nanomedicine Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 05-Sep-2020        Price: US 2800 Onwards        Pages: 95
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. The report includes as follows: The report provides current data, historical overview and future forecast. The report includes an in-depth analysis of the Global market for Nanomedicine , covering Global total and......
  • Covid-19 Impact on Global Nanopharmaceuticals Industry Research Report 2020 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2026
    Published: 06-Aug-2020        Price: US 2450 Onwards        Pages: 173
    The research team projects that the Nanopharmaceuticals market size will grow from XXX in 2019 to XXX by 2026, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2026. The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. ......
  • Global Nanopharmaceuticals Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026
    Published: 30-Jul-2020        Price: US 5900 Onwards        Pages: 129
    Nanopharmaceuticals market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Nanopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2015-2026. Segment by Type, the Nanopharmaceuticals m......
  • 2015-2025 Global Nanopharmaceuticals Market Research by Type, End-Use and Region (COVID-19 Version)
    Published: 29-Jul-2020        Price: US 2900 Onwards        Pages: 170
    Summary The global Nanopharmaceuticals market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025. Further key aspects of the report indicate that: Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size Chapter 2: Global Production & Consumption Market by Type and End-Use Chapter 3: Europe Production & Consumption Market by Type and End-Use Chapter 4: America Production & Consu......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs